who is not a candidate for glp 1 Are you good GLP-1 medication? Here what most platforms are telling you. π, GLP-1 drugs like semaglutide and tirzepatide are revolutionary. They are changing the landscape of Why I'm Choosing Not to
Description
We measure the odds ratio of developing pancreatitis between patients who have taken a large cumulative dose of GLP-1 agonist and those with a low cumulative dose of GLP-1 agonist

Investments in research and development are robust, as pharmaceutical companies vie to capture market share in a sector with immense potential

Sharing what this could mean for you.

People living with Crohn's disease face unique challenges when pursuing weight loss

Our GLP-1 Medical Weight Loss Program harnesses the power of Mounjaro, Wegovy or Zepbound to promote sustainable weight loss.
Newer dual GLP-1/GIP receptor agonists have been developed that can more easily cross the BBB and that show improved protection in animal models of AD and PD